ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 679266 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 679266; 2) Community: the network communities that were significantly associated with the response to NSC 679266; 3) Molecule: the relationships between components within communities and NSC 679266; 4) MDR: the compounds that were significantly associated with the NSC 679266.

NSC Compound Enrichment Correlation
NSC 680094 17-(O-Diethylaminoethyl)oximino-3-methoxy-1,3,5(10)- estratriene hydrochloride 0.0202245331784474 -0.070557025
NSC 683086 Boronic acid, [3-methyl-1-[[1-oxo-4-phenyl- 2-[[(2-quinolinyl)carbonyl]amino]butyl]amino]butyl]- 0.0202245331784474 -0.11305122
NSC 701314 1H,3H-Thiazolo[3,4-a]benzimidazole, 1-(2,6-dichlorophenyl)-6-methoxy- 0.0202245331784474 -0.25464978
NSC 703544 Null 0.0202245331784474 -0.13680838
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0202245331784474 -0.2479955
NSC 733504 Everolimus 0.0202245331784474 0.17886685
NSC 736157 Null 0.0202245331784474 0.41758077
NSC 758881 Orlistat (USAN) 0.0202245331784474 0.39516855
NSC 10037 Null 0.0202245331784479 -0.092070049
NSC 295500 Camptothecin Derivative 0.0202245331784479 0.35631836
Total:57  Current:22    [First] [Prev] [Next] [Last]